9th May 2022 11:24
4Basebio PLC - Heidelberg, Germany-based life sciences company - Nearly quintuples annual loss. 2021 pretax loss widens to GBP3.6 million from GBP716,000 in 2020. Revenue falls to GBP338,000 from GBP462,000 the year before. Research and development expenses grow to GBP1.6 million from GBP343,000. Administration costs rise to GBP1.7m from GBP516,000. "The group invested heavily during 2021," 4Basebio explains. 4Basebio listed on AIM in February of last year. Read More
